US 12,440,519 B2
Probiotic compositions for production of dopamine
Mark Lyte, Ames, IA (US); and Daniel Nicholas Villageliu, Ames, IA (US)
Assigned to lowa State University Research Foundation, Inc., Ames, IA (US)
Filed by Iowa State University Research Foundation, Inc., Ames, IA (US)
Filed on May 5, 2022, as Appl. No. 17/662,188.
Application 17/662,188 is a continuation of application No. 16/649,016, granted, now 11,357,803, previously published as PCT/US2018/052128, filed on Sep. 21, 2018.
Claims priority of provisional application 62/561,745, filed on Sep. 22, 2017.
Prior Publication US 2022/0313751 A1, Oct. 6, 2022
Int. Cl. A61K 35/744 (2015.01); A61K 9/00 (2006.01); A61K 31/198 (2006.01); A61K 31/675 (2006.01)
CPC A61K 35/744 (2013.01) [A61K 9/0053 (2013.01); A61K 31/198 (2013.01); A61K 31/675 (2013.01)] 6 Claims
OG exemplary drawing
 
1. A synbiotic composition comprising:
from about 104 CFU to about 1012 CFU of at least one bacterial strain comprising an Enterococcus spp. and/or a Vagococcus spp., wherein the bacterial strain produces dopamine; and
a time release prebiotic component comprising from about 1 mg/kg to about 100 mg/kg of L-DOPA.